Richard Smith, MD. Former Editor British Medical Journal (BMJ), a founder member of the Committee on Publication Ethics, a trustee of the UK Research Integrity Office. Dr. Smith is a fervent critic of current research and publication practices. In a provocative recent article in Times Higher Education (2015) he states,…
“Orgasmatron” implant experiment – legitimate or dubious? Fri, 28 Nov 2003 The FDA has approved what one can only call a bizarre expriment to test a surgically implanted device (orgasmatron) in the spine, of women–ostensibly to treat “sexual dysfunction.” To implant the device, “wires connected to a battery pack are…
A report in The New Scientist, "Prescribing of Hyperactivity Drugs is Out of Control," shows just how deviant U.S. prescribing of psychostimulants for
children is compared to the rest of the world.
Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency.
"Serotonin and depression: A disconnect between the advertisements and the scientific literature."
"Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
